Ross Warshauer
Analyste en capital-investissement chez 3i US
Postes actifs de Ross Warshauer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
3i US
 3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Analyste en capital-investissement | 01/09/2021 | - |
Historique de carrière de Ross Warshauer
Anciens postes connus de Ross Warshauer
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ten23 Health AG
 ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Directeur/Membre du Conseil | - | - |
Formation de Ross Warshauer
| Goizueta Business School-Emory | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Suisse | 2 |
Opérationnelle
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectorielle
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
3i US
3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Finance |
ten23 Health AG
ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Health Technology |
- Bourse
- Insiders
- Ross Warshauer
- Expérience
